These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7682376)

  • 1. Prenatal chromosome analysis today. Screening by maternal age or serum test?
    Salonen R
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):146-7. PubMed ID: 7682376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive means of identifying fetuses with possible Down syndrome: a review.
    Kubas C
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):27-46. PubMed ID: 10818852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum alpha-fetoprotein as screening test for Down syndrome.
    Brock DJ
    Lancet; 1984 Jun; 1(8389):1292. PubMed ID: 6202996
    [No Abstract]   [Full Text] [Related]  

  • 7. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is non-invasive diagnosis possible in Down's syndrome?
    Ioan DM; Lăpădat R
    Rom J Endocrinol; 1993; 31(3-4):199-200. PubMed ID: 7535157
    [No Abstract]   [Full Text] [Related]  

  • 10. Current techniques of prenatal screening for Down syndrome.
    Cardwell MS; Gay JW
    Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal screening for Down's syndrome: where are we and where next?
    Haddow JE
    Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical screening.
    Cuckle HS; Wald NJ
    Curr Opin Obstet Gynecol; 1990 Apr; 2(2):246-52. PubMed ID: 1714781
    [No Abstract]   [Full Text] [Related]  

  • 13. Down syndrome and low maternal serum alpha fetoprotein.
    Jacobs S; Giles W
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):335-40. PubMed ID: 1707270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal serum screening risk for Down syndrome is considered positive if a triple-marker-derived risk exceeds the age-specific risk: use of this definition for women aged 35 and over.
    Fitzgerald J; Streets K; Priest J
    Prenat Diagn; 1993 Feb; 13(2):152-3. PubMed ID: 7681979
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein and fetal autosomal trisomies.
    Doran TA; Cadesky K; Wong PY; Mastrogiacomo C; Capello T
    Am J Obstet Gynecol; 1986 Feb; 154(2):277-81. PubMed ID: 2418684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal serum screening for Down's syndrome in the first trimester of pregnancy.
    Biagiotti R; Cariati E; Brizzi L; D'Agata A
    Br J Obstet Gynaecol; 1995 Aug; 102(8):660-2. PubMed ID: 7544611
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal detection of Down syndrome in younger women.
    Singh DN
    Indian J Pediatr; 1989; 56(4):458-62. PubMed ID: 2483845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.